KRISTINA WAGGONER: Open Payments
NPI 1225422231 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 36 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $163 |
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| Merck Sharp & Dohme LLC | 6 | $113 |
| AstraZeneca Pharmaceuticals LP | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| AtriCure, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: REPATHA, LEQVIO, FARXIGA, VERQUVO, AMVUTTRA, ELIQUIS, CAPVAXIVE, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.
Industry payments across GA — which companies pay providers there.
